Filing Details
- Accession Number:
- 0001104659-15-000806
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-01-06 18:09:06
- Reporting Period:
- 2015-01-02
- Filing Date:
- 2015-01-06
- Accepted Time:
- 2015-01-06 18:09:06
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1410939 | Ophthotech Corp. | OPHT | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1277476 | R David Guyer | C/O Ophthotech Corporation One Penn Plaza, 19Th Floor New York NY 10119 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2015-01-02 | 15,034 | $10.03 | 15,034 | No | 4 | M | Direct | |
Common Stock | Disposition | 2015-01-02 | 6,568 | $44.91 | 8,466 | No | 4 | S | Direct | |
Common Stock | Disposition | 2015-01-02 | 8,466 | $45.68 | 0 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right To Buy) | Disposition | 2015-01-02 | 15,034 | $0.00 | 15,034 | $10.03 |
Common Stock | Option (Right to Buy) | Acquisiton | 2015-01-02 | 91,500 | $0.00 | 91,500 | $45.60 |
Common Stock | Restricted Stock Units | Acquisiton | 2015-01-02 | 23,000 | $0.00 | 23,000 | $0.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
436,832 | 2023-04-25 | No | 4 | M | Direct | |
91,500 | 2025-01-01 | No | 4 | A | Direct | |
23,000 | 2025-01-01 | No | 4 | A | Direct |
Footnotes
- The exercises and sales reported on this form were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 15, 2013.
- These shares were disposed of in multiple transactions on January 2, 2015 at actual sales prices ranging from $44.46 to $45.45 per share. The price reported reflects the weighted average sale price for the transactions. The reporting person undertakes to provide upon request by the staff of the Securities Exchange Commission, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- These shares were disposed of in multiple transactions on January 2, 2015 at actual sales prices ranging from $45.47 to $46.05 per share. The price reported reflects the weighted average sale price for the transactions. The reporting person undertakes to provide upon request by the staff of the Securities Exchange Commission, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- This option was granted on April 26, 2013 and vests as to 1/48 of the shares underlying such option each month until April 2017.
- Subject to continued employment with the Registrant and the other terms and conditions under the Registrant's 2013 Stock Incentive Plan, each of these stock option awards will vest with respect to 25% of the shares subject to the option on the first anniversary of the grant date and with respect to the remaining shares in approximately equal monthly installments through the fourth anniversary of the grant date.
- Each restricted stock unit represents the contingent right to receive one share of common stock upon vesting of the unit.
- Subject to continued employment with the Registrant and the other terms and conditions under the Registrant's 2013 Stock Incentive Plan, each of these Restricted Stock Unit awards will vest with respect to 25% of the shares subject to the award on each of the first, second, third and fourth anniversaries of the grant date.